ã¡ãã£ã¢èšäº
HPVã¯ã¯ãã³ã®ãç©æ¥µçå§å¥šãåéãååŽçæ€èšãžã22幎床èŠéã«
ããºãææ°ããŒã¯ 713
twitterã³ã¡ã³ã 485ä»¶äž 1ïœ100件
女åã®çãããä»ãŸã§æ¶æ¥µçã«ãªã£ãŠãã®ã¯ãå¯äœçšããå€æ°ãã£ãããã£ãŠããã ãã ãããæã£ãæ¹ããããã
ãåçåŽåçã¯2013幎ããå·®ãæ§ããŠããç©æ¥µçãªæ¥çš®åŒã³ããã®åéã«åããè°è«ãå§ãããæ¥å¹ŽåºŠããã®åéãèŠéã«æ€èšããã
ãåå®®é žãããªã©ã®åå ãšãªãHPVïŒç¥ïŒã®ææãé²ããšãããã¯ã¯ãã³ããå
šèº«ã®çã¿ãªã©ã®çç¶ãçžæ¬¡ãã§å ±åããããããååŽçã¯å¯Ÿè±¡è
ã«æ¥çš®ãåå¥ã«åŒã³ããããç©æ¥µçå§å¥šãããããŠããã
ã70ïŒ
以äžã ã£ãåœå
ã®æ¥çš®çã¯02幎以éã«çãŸãã人ã§ã¯1ïŒ
æªæºã«ããååŽçã¯ç¡æã®æ¥çš®æ©äŒãéã人ãæžããããæšå¹Ž10æãèªæ²»äœã«å¯ŸããŠå¯Ÿè±¡è
ãžåå¥ã«HPVã¯ã¯ãã³ã«é¢ããæ
å ±ãç¥ãããããéç¥ã
åæã«æ¥å¹Žã«æã¡è¶ããªãããªïŒïŒ
䞻矩䞻匵ãè¶
ããŠ
è¥ã女æ§ã®ããã«èŠæ決ããŠçéã§æœåããããåãããããé¡ãããŸã
è¥ã女æ§ã®ããã«èŠæ決ããŠçéã§æœåããããåãããããé¡ãããŸã
ç©æ¥µçã§ã¯ãªãã矩ååãã¹ãã ã銬鹿ãªãã¹ã³ããHPVã¯ã¯ãã³ã®å¯äœçšãç
œã£ãããšã§ãåå®®é ãããå¢å ããããšã¯ãæ¥æ¬ã®å»çã®æ倱ã§ããã
ãã£ã³ã¹ã¯ä»ãããªã
ãã£ãšãã
ããŒã¿ãææãæ¢ã«ãããã ããããããŠãã£ã¡ã¯èŠæ決ããŠçéã§æœåããŠæ¬²ãããªãâŠ
ç¥Â·å³æå®æœãžâŒïžïŒ
ããã¯ã€ãã€
ããããã§ãã
匷åã«æšãé²ããŠãŸãããŸãããã
ããšã¯ç©æ¥µçå§å¥šããããŠããææã®å¯Ÿè±¡è ãžã®ãã©ããŒãšç·åãžã®æåãå®ææåãžã
匷åã«æšãé²ããŠãŸãããŸãããã
ããšã¯ç©æ¥µçå§å¥šããããŠããææã®å¯Ÿè±¡è ãžã®ãã©ããŒãšç·åãžã®æåãå®ææåãžã
éåžžã«éèŠãã€é倧â察å¿ã®ãç²æ«ããæ匟ãããããã©å§å¥šæ€èšã«å
¥ã£ãã ãã§ãè©äŸ¡ããããäžäººã§ãå€ãã®äºº(ç·å¥³å
±)ãå©ãã£ãŠã»ãã(>_<)
ç©æ¥µçå§å¥šããããåŸã70ïŒ
以äžã ã£ãåœå
ã®æ¥çš®çã¯02幎以éã«çãŸãã人ã§ã¯1ïŒ
æªæºã«äœäž
åçåŽåçã¯2013幎ããå·®ãæ§ããŠããç©æ¥µçãªæ¥çš®åŒã³ããã®åéã«åããè°è«ãå§ãã
åçåŽåçã¯2013幎ããå·®ãæ§ããŠããç©æ¥µçãªæ¥çš®åŒã³ããã®åéã«åããè°è«ãå§ãã
ãã£ãšã¹ã¿ãŒãå°ç¹ã ãHPVãšåå®®é žããã®å æé¢ä¿ã¯æããã§ããåã¯ã¯ãã³æŽŸã®çœªã¯éãããé²ããããã¯é²ããŸãããã
ãªãã§ãååŽçã¯ãããªã«ã¡ãããããŠãã®ããã(ÂŽÏïœ) â
ååŽçã¯äœãæããŠãã®ã§ããããâŠ
ééããªãHPVã¯ã¯ãã³åéå 延ã°ãããŸãããŒð¥²
ééããªãHPVã¯ã¯ãã³åéå 延ã°ãããŸãããŒð¥²
ãããã£ããïŒãªã¹ã¯ãèãããšãããªããšããããšãšæãããå®éã«ããããŸã§ã«æ¥çš®ã®åœ±é¿ã§æ®éã®ç掻ãéããªãç¶æ³ã«ãªã£ã人ãããã®ã§ããã®åå è¿œåïŒç¹ã«ã¢ãžã¥ãã³ãïŒã¯åŸ¹åºçã«ãé¡ãããŸãã
åå®®é žããã¯ã¯ãã³ã®ç©æ¥µçæšå¥šã22幎床ãèŠéã«åéæ€èšãžã
ç¹ã«æšå¥šããŠããã®ããã«ã»ã²ã€ãããæè¬ç¶ãè²°ã£ãŠããå ¬æå ïŒåµäŸ¡ã
çµå±ã¯ããã人å£åæžèšç»ã®äžç°ã§ãã
ã¯ã¯ãã³ã¯çæ¯ã§ãã
ç¹ã«æšå¥šããŠããã®ããã«ã»ã²ã€ãããæè¬ç¶ãè²°ã£ãŠããå ¬æå ïŒåµäŸ¡ã
çµå±ã¯ããã人å£åæžèšç»ã®äžç°ã§ãã
ã¯ã¯ãã³ã¯çæ¯ã§ãã
ç©æ¥µçå§å¥šãããããŠããäœãã¯ãªã¢ã«ãªã£ãŠåéãªã®ãããããšããã³ããã®äºé²æ¥çš®ã®æ©éãé«ãŸã£ãŠããã¡ã«äŸ¿ä¹ããŠç©æ¥µçå§å¥šã«ãã¡ãŸãã£ãŠããšããç¡ããããªã
åã«ãèšã£ãããããã¯ç·ãæããªããã°æå³ãç¡ãð
HPVãŠã€ã«ã¹ã¯æ§è¡çºãä»ããŠææããããããŠç·ãäžåœé ãããé°èãããèéããã®ãªã¹ã¯ãããâŠ
HPVãŠã€ã«ã¹ã¯æ§è¡çºãä»ããŠææããããããŠç·ãäžåœé ãããé°èãããèéããã®ãªã¹ã¯ãããâŠ
é
ãŸããªãããæ¥é±1åç®ã®æåäºçŽããã120æ³ãŸã§çããã®ã§ããšãå°ããªç¢ºçã§ãã£ãŠããã£ã¡ãäºé²ããŠããããã
æ¯æ¥æ°èãšãææ¥æ°èã¯åå®®é žããã®æ£è
ãå¢ãããæ¥æ¬ã®å¥³æ§ã幎é3000人ã殺害ããããšã«æåããŠãããããããã®ã§ããããåã³è
°ã®ååŽçãã¯ã¯ãã³ãå§å¥šãããšã®äºãæ®å¿µã§ããã
ããããææ¥æ°èãããªããèšããïœïœïœ
ããããã°ååŽçãæ¥åã£ããã®ä»¶ã ãããã£ã±ãæ¥çš®æšå¥šã£ãŠããšã§ãããããªïŒ
å¿ããé ã«ã¡ããã¡ããã¶ã£ãããå·å¿µã ãã
ç·åã«ãåºããŠãã
ãã²ãæ©æã«æšå¥šã®æ¹åã«åããŠããããšãæã¿ãŸãã
é žããã¯ã¯ãã³ã®æ®åçããã®ããã«ç ç²ã«ãªãåœã®å€ãã¯å é²åœãšã¯æããªãçŸç¶ã§ãã
é žããã¯ã¯ãã³ã®æ®åçããã®ããã«ç ç²ã«ãªãåœã®å€ãã¯å é²åœãšã¯æããªãçŸç¶ã§ãã
è¯ãåŸå
ããæãšããšæã£ãé ã«éšãã«ãªã£ãŠãããŠããŸã£ã
æ¬åœã¯æã¡ãããã©é«ããŠç¡çãŒ
æ¬åœã¯æã¡ãããã©é«ããŠç¡çãŒ
ç·åãæ¯éïŒ
ç·åãžã®æ¥çš®ã®æ€èšãã䜵ããŠé²ããŠæ¬²ããã
HPVã¯ã¯ãã³æ¥çš®ã«ããå¯åå¿è¢«å®³è
ãã¡ã¯çŸåšããªããé節ãªçç¶ã«èŠããã§ããŸãããã®è¢«å®³ãæŸçœ®ãããŸãŸç©æ¥µçå§å¥šãåéããããšã¯èš±ãããŸããã
HPVã¯ã¯ãã³æãšãããšæããã©ç·æ§ã«ãè£å©ãããã ãããã
ãããæãç
æ°ã ãããã£ãæ¹ããããã
æ§äº€åæ°ãå€ã人ã»ã©HPVïŒããããããŒããŠã€ã«ã¹ïŒãã£ãªã¢ãå€ãã®ã§ã¯ãªãã
æ§äº€åæ°ãå€ç°ãŠã€ã«ã¹ãäœãåºã
ã¯ã¯ãã³ã¯å¹ããªããªã
éã«ææå¢åŒ·ð¡
æ§äº€åæ°ãå€ç°ãŠã€ã«ã¹ãäœãåºã
ã¯ã¯ãã³ã¯å¹ããªããªã
éã«ææå¢åŒ·ð¡
ååŽçãæ¥å¹ŽåºŠãèŠéã«HPVã¯ã¯ãã³ã®ç©æ¥µçå§å¥šãåéããèšç»ã®ããã ãããããã£ããããªã¹ã¯ã倧ããäžåãããæã£ãæ¹ããããšæã
åå ã¯å ±éã ã£ããã ããåãèœãèžãŸãªãããã«ããªããšãååªäœãæ¿æ²»çææ³ãæã€ã®ã¯ä»æ¹ããªããã©å¥åº·åé¡ã§åœæ°ã®è¶³ãåŒã£åŒµã£ãã®ã¯ããååŒããŠãé±éãŽã·ããèªãããªããã ããã
鬌æ»
ã®åãã«ãã²ãšãããã
åŠæ ¡ç掻ãããã«ã¯ãŒã«ãã
åŠæ ¡ç掻ãããã«ã¯ãŒã«ãã
æ°åã³ããã¯ã¯ãã³ã®åœæ°çæ¥çš®ã«ãã£ãŠHPVã¯ã¯ãã³ãžã®å¿é¿æãç·©åããããšå€æããã®ããããããªåããå§ãããããç©æ¥µçå§å¥šããããããã£ããã«ãªã£ãã®ããå®ææ¥çš®ããçŽåŸã«å
šèº«ã®çã¿çã®çç¶ãçžæ¬¡ãã§å ±åãããçºãããããããã®å¯äœçšåé¡ã¯è§£æ±ºããããïŒ
ããããäœãæ¹åãããŠãªãã®ã«ïŒ
ãã®ã¯ã¯ãã³ã ãã¯ãã¡
ãŸã ããããªãã®ã
çŸå®³ãã£ãŠäžå©ãªãã®å žåã¿ãããªãã®
ãã®ã¯ã¯ãã³ã ãã¯ãã¡
ãŸã ããããªãã®ã
çŸå®³ãã£ãŠäžå©ãªãã®å žåã¿ãããªãã®
ç§ç·ã ãã©æã¡ãã
äžççã«ã¯ç·ã«ãæã£ãŠããèªå¯ããŠåœè£å©ã®æ¥çš®ã®èªç±ã欲ããã§ã
äžççã«ã¯ç·ã«ãæã£ãŠããèªå¯ããŠåœè£å©ã®æ¥çš®ã®èªç±ã欲ããã§ã
ãåå®®é žçã¯ã¯ãã³ã®ãç©æ¥µçå§å¥šãåéãååŽçæ€èšãž 22幎床èŠéã«ããšããèšäºãåå®®é žçã¯ã¯ãã³ã®åšåº«åŠåã§ãïŒãã¯ã¯ãã³æ¥çš®ã§44.6%ãåå®®ççºççãäžæããäžåŠåã«ãªãããšç±³åœFDAãçºè¡šããŠããã«ãé¢ããããååŽçã¯ãããåã³æšå¥šããããã§ãïŒé¬Œçã§ãïŒ
人殺ãæ¿æš©ãæ¬åœã«äººæ®ºãã®ããšããèããŠãªãã
ãããã©ãããçŽãã«ããããšããŠãããå°åºèš±ããªãã
ãããã©ãããçŽãã«ããããšããŠãããå°åºèš±ããªãã
ããããã¹ã³ãã®çãããã©ãããæ
床ã§èšãã®ããªïŒïŒ
ã»éå»ã®éã¡ãèªããäžã§ãæšå¥šã®è«èª¿ãž
ã»ããã£ãšæšå¥šã«
ã»æ¿åºã®å¯Ÿå¿ã®é ããæ¹å€
ã»éå»ã«ç¿ããåã¯ã¯ãã³è«èª¿
ã»éå»ã®éã¡ãèªããäžã§ãæšå¥šã®è«èª¿ãž
ã»ããã£ãšæšå¥šã«
ã»æ¿åºã®å¯Ÿå¿ã®é ããæ¹å€
ã»éå»ã«ç¿ããåã¯ã¯ãã³è«èª¿
ãã©ã³ã¹ãžã§ããã¯ããïŒ
PCRè£å©éãè²°ã£ãã
PCRè£å©éãè²°ã£ãã
â ãã®ä»
ïŒ âŒ æ°åã³ãããŠã€ã«ã¹
NHKïŒãåœå ææãæ°åã³ãã 65人æ»äº¡ 1äž7713人ææïŒ31æ¥18:35ïŒ
ïŒ âŒ å»ç
ååŽçïŒ
ïŒ âŒ æ°åã³ãããŠã€ã«ã¹
NHKïŒãåœå ææãæ°åã³ãã 65人æ»äº¡ 1äž7713人ææïŒ31æ¥18:35ïŒ
ïŒ âŒ å»ç
ååŽçïŒ
åœã«é¢ããåé¡ã¯ææ
ãææ³ä¿¡æ¡ãããªãããšããã³ã¹ãåºã«èããã¹ãããšããããäžæ©åé²ã¯äœ³ãããšã
ã¶ã£ã¡ããããã®è©±ã§äžçªä¿¡çšåºæ¥ãªãç¹ã¯ãCOVID-19ãã¯ã¯ãã³ã ãã§ã»ã£ãœãããã«ããã°ããã§ãªããæ²»çè¬ãå©ã朰ããŠåœæ°ã®ç ç²ã®ããšéå£å
ç«ãç®æããŠããå»ã¯ã©ã©ãããMSDã®è
ããããã¯ã«æšå¥šããŠããäºâŠ
8幎éã®ç©ºçœã®åœ±é¿ã¯ãåå®®é žããã®åé§çãªç
æ°ãåå®®é žããèªäœã®å¢å ã§èŠããŠããã®ããª(ÂŽÏïœ) â
ãã¢ çŽ æŽãããïŒ
æå¹æ§ã¯ç解åºæ¥ãããäžå®èŠçŽ ãææåºæ¥ãããå ã
ãšéå»ã®ãã©ãã«ã倧ããªå£°ã§å
¬è¡šãã¹ãã ã
ã³ããã®ã¯ã¯ãã³ã§ããããã©ãã«ãèµ·ããããã¡ããšèª¿æ»ããŠå€§ã çã«çºè¡šããŠããã®ã ããïŒ
ã³ããã®ã¯ã¯ãã³ã§ããããã©ãã«ãèµ·ããããã¡ããšèª¿æ»ããŠå€§ã çã«çºè¡šããŠããã®ã ããïŒ
åœæ°ã殺ã
ç·æ§ãžã®ç¡ææ¥çš®ãæ€èšããŠã»ããã
å°ãã ãååŽçã§HPVã¯ã¯ãã³åé¡ã«é¢ãã£ããšãããããªã«ç©¶æ¥µçã«é£ããè¡æ¿èª²é¡ãããã®ããšé©ããã
ç©æ¥µçå§å¥šãåéããããåéãŸã§ã®éã®ããå ¬éããŠæ¬²ããã
ãã®ãŸãŸå ¬åå¡ã®æç§æžã«ãªãã
é¢ãã£ãå šãŠã®äººã«å°æ¬ãããªãã
ç§ã¯è¿ã æã¡ã«è¡ããŸãã
ç©æ¥µçå§å¥šãåéããããåéãŸã§ã®éã®ããå ¬éããŠæ¬²ããã
ãã®ãŸãŸå ¬åå¡ã®æç§æžã«ãªãã
é¢ãã£ãå šãŠã®äººã«å°æ¬ãããªãã
ç§ã¯è¿ã æã¡ã«è¡ããŸãã
ãã¡ã¯ãäºäººåšããŸããåããŠãŸãããå¯äœçšãäžææãããèšãããŠããŠãåœãæšå¥šããªããªã£ãŠãã®ã§ãåšããããæ¹ã®ãæèŠãèãããã
æ€èšã§ã¯ãªããã決å®ãããŠã»ããã
ãããïŒæ¯éæ€èšããŠã»ããããããŠæ人女æ§ã§ãåããã9䟡ã¯ã¯ãã³ãæ¥çš®è£å©ãã§ãããã«ããŠã»ããïŒïŒ
ç§ã¯HPVã¯ã¯ãã³ã«åŠå®çãªãã ãã©ãåœå
ã§ãã©ã»ãè©Šéšããã£ãŠããªããèšåºè©Šéšã§ã¯1%ã§é節ãªçç¶ã0.1%ã§æ»äº¡ãšããã¯ã¯ãã³ãæã¡ããããïŒçã§æ»ã¬æ¹ããã£ãœãšç¢ºçäœããªãïŒ
ã¯ããæ¥ãŸããããããªãã¹ã¿ãŒãããŠãããã¹ã ãŒãºãšæãã°ã
ãããªãšã
ãããªãšã
é¢ãã人ãã¡ããªããªãã«ããã£ãšããŸãåºå ±ãã«ãã
ãããªãšã
ãããªãšã
é¢ãã人ãã¡ããªããªãã«ããã£ãšããŸãåºå ±ãã«ãã
å¯åå¿ã«ã¯è£åãå¿
èŠã ããåå®®çãèãããšãã®éãããªããšæãã
COVID-19ã®ã¯ã¯ãã³ã¯ãCMãåºåãã£ãŠããã ãããHPVãæ§ããã®ã¯ããã¹ã¿ã§ãããããåççã§ã¯ãªããšæããŸããã©ã¡ãã®ã¯ã¯ãã³ããæ¬äººãçŽåŸããŠæ¥çš®ããããšã«æ矩ããããšæããŸãã
æ¯æ¥ãŸã§âŠäœãæªããã®ã§ãé£ã¹ãããâŠ
å
ç¥çæ¯æ®ºäººå
µåš
é
ããåå®®é žããã¯ã¯ãã³ã®æå¹æ§ã¯é«ããšããããŒã¿ãååœã§åºãŠãããä»»æã ãšãç§ã®ãããªãŠãã«ãªæ¯ã¯ã䞻治å»ã«èšããæ°ã¥ãããæã«ã¯å©æãªãã®é«ïŒã§ã3å5äžä»¥äžð± ãã®å€æ®µãèããåšã¯ã倧åŠè¡ã£ãŠãã9䟡ãèªè²»ã§æã€ãšæ±ºãããããã
åå®®é žïŒããïŒãããªã©ã®åå ãšãªãHPVïŒããããããŒããŠã€ã«ã¹ïŒã®ææãé²ããšãããã¯ã¯ãã³ã«ã€ããŠãåçåŽåçã¯2013幎ããå·®ãæ§ããŠããç©æ¥µçãªæ¥çš®åŒã³ããã®åéã«åããè°è«ãå§ããã
ã70ïŒ
以äžã ã£ãåœå
ã®æ¥çš®çã¯02幎以éã«çãŸãã人ã§ã¯1ïŒ
æªæºã«äœäžããã¡ãŒã«ãŒãããã以äžã¯ã¯ãã³å»æ£ãããªãæ¥æ¬åãã«è£œé ããã®ãèãçŽããšèŠåãããŠãããâ
ã¡ããã¢ãã
HPVã¯ã¯ãã³ãªãâŠ
åšã17ã®ãšãã倫ã«ãã®ããã説æããŠããããã€ãå»ã«èããããã¯ã¯ãã³æ¥çš®ã¯ããŠãŸããããšèšãããŠåž°ã£ãŠããŠãã»ããšã«ãã£ããããã
ã¡ãããšè¡æ¿ããéç¥ããŠãåœããåã«ã¯ã¯ãã³æãŠãããã«ãªã£ãŠæ¬²ããã
åšã17ã®ãšãã倫ã«ãã®ããã説æããŠããããã€ãå»ã«èããããã¯ã¯ãã³æ¥çš®ã¯ããŠãŸããããšèšãããŠåž°ã£ãŠããŠãã»ããšã«ãã£ããããã
ã¡ãããšè¡æ¿ããéç¥ããŠãåœããåã«ã¯ã¯ãã³æãŠãããã«ãªã£ãŠæ¬²ããã
HPVã¯ã¯ãã³çµ¶è³ãã声ãå€ãããŠæ°æã¡æªããç©æ¥µçå§å¥šããããçç±ããã£ãã¯ããåéããã®ã«èª¬æãã£ãã£ãïŒ
éå£èšŽèšã¯ä¿äºäžã
ã³ããã¯ã¯ãã³è¢«å®³å¯Ÿå¿ãã ãã©ãèª å®ããæããªãã
éå£èšŽèšã¯ä¿äºäžã
ã³ããã¯ã¯ãã³è¢«å®³å¯Ÿå¿ãã ãã©ãèª å®ããæããªãã
HPVã¯ã¯ãã³ãåéãããã«ã圹æã«ãªãœãŒã¹ãç¡ãããå
éãããããç¡ããããªçµ¶ææâŠ
ã2021/8/30ãèªæ°ãHPVã¯ã¯ãã³ã®ç©æ¥µçå§å¥šåéãç®æãè°å¡é£çãïŒçŽ°ç°åä¹äŒé·ïŒååŽã2013幎ããå·®ãæ§ããŠããç©æ¥µçãªæ¥çš®åŒã³ããã®åéã«åããè°è«ãå§ããã審è°äŒã«è«®ããæ¥å¹ŽåºŠããã®åéãããHPVã«ã€ããŠã®æ
å ±ãåºãçºä¿¡ããäŒãæ°æ¥éã¢ãªãã€çœ²åå©ççžå
ãããããã
ã³ããã®ã¯ã¯ãã³ã§ããå¯åå¿ããŒã£ãŠå€§éšããããäžã®äžã ããã©ãæ£ããç¥èãäŒãã£ãŠãæ£ããäºé²ç«åŠãåºãŸã£ãŠæ¬²ããã
ã³ããã®ã¯ã¯ãã³ã§ããå¯åå¿ããŒã£ãŠå€§éšããããäžã®äžã ããã©ãæ£ããç¥èãäŒãã£ãŠãæ£ããäºé²ç«åŠãåºãŸã£ãŠæ¬²ããã
ç§ãé«æ ¡çã®æãåžãããã¬ã(æ€æ»ã泚å°)ãããã©åœæã¯ã¯ãã³ã®å±éºæ§ãããããå ±éãããŠããŠã婊人ç§ã§ãæ€æ»ã§ãããšããããŠæªæ¥çš®ãä»ããã§ãæã¡ãããã©ä»å人ã§æã€ãš5äžãšãããã
æ°ã³ãmRNAåæ§ã«è¢«å®³è
ã®è¬å®³ãèªãã¬ã ãã§ãå®å
šæ§ã確èªãããŠãã¯ãªãã ãâïž
çš²èå¯å¥åå»åž«ã¯ãå®å šæ§ã確èªãããŠããã¯ã¯ãã³ã«ã€ããŠãåœæ°ã®å¥åº·ãå®ãçºã«åœã¯è²¬ä»»ãæã£ãŠç©æ¥µçå§å¥šãããšåŒ·èª¿ãååãªå¹æã«3åæ¥çš®ãå¿ èŠãé«æ ¡1幎çã¯é ããšã11æã«1åç®ãã
çš²èå¯å¥åå»åž«ã¯ãå®å šæ§ã確èªãããŠããã¯ã¯ãã³ã«ã€ããŠãåœæ°ã®å¥åº·ãå®ãçºã«åœã¯è²¬ä»»ãæã£ãŠç©æ¥µçå§å¥šãããšåŒ·èª¿ãååãªå¹æã«3åæ¥çš®ãå¿ èŠãé«æ ¡1幎çã¯é ããšã11æã«1åç®ãã
æ¥æ¬ã®ã¯ã¯ãã³éçºãæ¢ããŠã¯ã¯ãã³ãžã®äžå®ãåãããã®ã¯2013幎ã«ãã¹ã³ãç·åºã§åHPVã¯ã¯ãã³å ±éããããã端ç·ãéããã®ã¯ææ¥æ°èã§ããã
ãååŽçãHPVã¯ã¯ãã³ãç©æ¥µçå§å¥šãåéæ€èšãžãæ¥å¹ŽåºŠèŠéã«ãæ¯æ¥æ°è
ãååŽçãHPVã¯ã¯ãã³ãç©æ¥µçå§å¥šãåéæ€èšãžãæ¥å¹ŽåºŠèŠéã«ãæ¯æ¥æ°è
æ¯æ¥ã¯æ¿åºãååãã«åãçµãã§ããããã«ããžãã£ããªæžãæ¹ã ãã©ããããããŸããã®ïŒ
å¯åå¿ã«ã€ããŠãã¡ããšæ€èšŒããæ
å ±é瀺ã被害è
ãžã®æ²»çãè£åã«ã€ããŠã®å¶åºŠãæŽããŠããã«ããŠäžããã
ãã£ãããæ
å ±åéããŠããªã¹ã¯ãšãªã¿ãŒã³ãåæ¡ããŠå€æããã
ïŒ70ïŒ
以äžã ã£ãåœå
ã®æ¥çš®çã¯02幎以éã«çãŸãã人ã§ã¯1ïŒ
æªæºã«äœäž
ïŸïœœïœºïŸã®çæ§ã®åŸ¡å°œåã®è³ç©
ïŸïœœïœºïŸã®çæ§ã®åŸ¡å°œåã®è³ç©
8æ30æ¥
絶察ã«æã£ã¡ããã¡ââŒïž
ç¡çç¢çãäºå®ãæšãé²ããŠããªãäžä¿¡ã¯ããããå¢ãäžæ¹ãªã®ã«ã
ããïŒèšŽèšãèµ·ããŠãŸããã§ããã£ãïŒ
ä»é æ€èšããïŒäžçã®éåžžèååŽç
äžèšãšåæ¥åºããã¥ãŒã¹ãšã¯æããªããã
å ±éã®ä»æ¹ã§æ£å察ã®ãã¥ãŒã¹ã®ããã«åãæ¢ããããã
NHKã®å ±éãããããã®ãïŒïŒ
å ±éã®ä»æ¹ã§æ£å察ã®ãã¥ãŒã¹ã®ããã«åãæ¢ããããã
NHKã®å ±éãããããã®ãïŒïŒ
ãŸããã¹ã³ãã«ããé床ãªãã¬ãã£ããã£ã³ããŒã³ãå§ãŸããªããšãããã©ãå§ãŸããã ãããª
äžåŠåãšäººå£åæžã«æè»ããããããšããŠããã®ããªð€(é°è¬è³)
ãã®äºé²æ¥çš®ã§é²ããã¯ãã®ããã§äº¡ããªã£ãæ¹ã
ã®ãéºæã®èšèãèŸãã£ãã
ãããŒð
ã³ã¡ãšãèŠãŠããšèª€è§£ããŠã人ãããããªã®ã§âŠ
â äžåºŠã§ãæ§è¡çºããããšã¯ã¯ãã³ã¯æå³ãªããšæã£ãŠã人ãããããã ãã©ãæ§è¡çºãããã°å¿ ããŠã€ã«ã¹ã«ææãããšããããã§ã¯ãªãã®ã§ãæ§è¡çºã®çµéšããã£ãŠããŠã€ã«ã¹ã«ææããåãªãã¯ã¯ãã³ã®å¹æã¯ãããâ
â äžåºŠã§ãæ§è¡çºããããšã¯ã¯ãã³ã¯æå³ãªããšæã£ãŠã人ãããããã ãã©ãæ§è¡çºãããã°å¿ ããŠã€ã«ã¹ã«ææãããšããããã§ã¯ãªãã®ã§ãæ§è¡çºã®çµéšããã£ãŠããŠã€ã«ã¹ã«ææããåãªãã¯ã¯ãã³ã®å¹æã¯ãããâ
ãã®ã¯ã¯ãã³ã¯æ¬åœã«å€§äžå€«ãªã®ãïŒ
ãã£é 匵ã£ãŠããïœ
å¯åå¿ãæãã®ã¯çåãã§ã©ãã§ããããšããããªããšã¯æã£ãŠãªãã¯ãã人äœã«å¯Ÿãããªã¹ã¯ãŒãã¯èª°ããæãããšããªãã¹ããŒãã«è¿ã¥ãããããã«ç 究è
ãå»çé¢ä¿è
ã®æ¹ã
ãªã©åãçµãã§ããã ããŠãããšæã£ãŠãŸãã
ããããããšããæ°æã¡ã匷ããå°ãã§ãåã«é²ãã ãšæãããããããŠç·æ§ã«ãæ¥çš®å§å¥šãã
ãç©æ¥µçå§å¥šãã®åéã¯æ¯éè¡ãã¹ãã ããããããç©æ¥µçå§å¥šããäœãªã®ã極ããŠææ§ã ããã®èšäºã®ãååŽçã¯å¯Ÿè±¡è
ã«æ¥çš®ãåå¥ã«åŒã³ããããç©æ¥µçå§å¥šãããããŠãããããšãèªæ²»äœã«å¯ŸããŠå¯Ÿè±¡è
ãžåå¥ã«HPVã¯ã¯ãã³ã«é¢ããæ
å ±ãç¥ãããããéç¥ãããã®ïŒç¶ãïŒ
äžå¿åããŠã¯ããããã§
HPVã¯ã¯ãã³æ¥çš®ãå
é²åœã§æ¥æ¬ãé
ããŠããåå ã¯ãææ¥æ°èã®ååå ±éã
æ¥æ¬åœãšåœæ°ã«å®å®³ãšä»åœãšã®é¢ä¿æªåãåãŒãææ¥æ°èã®ææ³äŒæãè¡ã姿å¢ã¯ãŸãã«èŠéã
æ°åã³ãããŠã€ã«ã¹ã«ã€ããŠã®å ±é姿å¢ãåæ§ãæ°å€ã«åºã¥ããåœæ°ã®äžå®ãç œã圌ãã¯æ¥æ¬ã«äžèŠã ã
æ¥æ¬åœãšåœæ°ã«å®å®³ãšä»åœãšã®é¢ä¿æªåãåãŒãææ¥æ°èã®ææ³äŒæãè¡ã姿å¢ã¯ãŸãã«èŠéã
æ°åã³ãããŠã€ã«ã¹ã«ã€ããŠã®å ±é姿å¢ãåæ§ãæ°å€ã«åºã¥ããåœæ°ã®äžå®ãç œã圌ãã¯æ¥æ¬ã«äžèŠã ã
ã ããã©ãã€ã®ããã§ããŒãªã£ããã ãæ¡ä»¶ãªâŠð€ãåããå¯åå¿ãšæ害äºè±¡ã®åºå¥ãç¥ããªãã§å¥œãåæéšãã ããã ãâŠ
å㞠次ãž